ATE226069T1 - Verwendung von alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur behandlung von entzündlichen darmerkrankungen - Google Patents
Verwendung von alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur behandlung von entzündlichen darmerkrankungenInfo
- Publication number
- ATE226069T1 ATE226069T1 AT97830270T AT97830270T ATE226069T1 AT E226069 T1 ATE226069 T1 AT E226069T1 AT 97830270 T AT97830270 T AT 97830270T AT 97830270 T AT97830270 T AT 97830270T AT E226069 T1 ATE226069 T1 AT E226069T1
- Authority
- AT
- Austria
- Prior art keywords
- carnitines
- inflammatory bowel
- alkanoyl
- treatment
- production
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 241000792859 Enema Species 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- -1 alkanoyl L-carnitines Chemical class 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000007920 enema Substances 0.000 abstract 1
- 229940079360 enema for constipation Drugs 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96RM000396A IT1284661B1 (it) | 1996-06-06 | 1996-06-06 | Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226069T1 true ATE226069T1 (de) | 2002-11-15 |
Family
ID=11404269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97830270T ATE226069T1 (de) | 1996-06-06 | 1997-06-03 | Verwendung von alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur behandlung von entzündlichen darmerkrankungen |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6013670A (de) |
| EP (1) | EP0811376B1 (de) |
| JP (1) | JP4171085B2 (de) |
| KR (1) | KR100450293B1 (de) |
| AT (1) | ATE226069T1 (de) |
| CA (1) | CA2206995C (de) |
| DE (1) | DE69716341T2 (de) |
| DK (1) | DK0811376T3 (de) |
| ES (1) | ES2185897T3 (de) |
| IT (1) | IT1284661B1 (de) |
| MX (1) | MX9704150A (de) |
| PT (1) | PT811376E (de) |
| TW (1) | TW585763B (de) |
| ZA (1) | ZA974946B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6348495B1 (en) * | 1996-06-06 | 2002-02-19 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Method for treating celiac disease |
| EP0972516A1 (de) * | 1998-06-25 | 2000-01-19 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | L-Carnitin ersetzende Zusammensetzung ohne gastrointestinale Nebenwirkungen |
| US20010025027A1 (en) * | 2000-03-07 | 2001-09-27 | Sonis Stephen T. | Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation |
| JP4104834B2 (ja) * | 2001-04-13 | 2008-06-18 | 株式会社東芝 | Ｍｉｓ型電界効果トランジスタの製造方法 |
| ITRM20040168A1 (it) * | 2004-04-01 | 2004-07-01 | Sigma Tau Ind Farmaceuti | Composizione a rilascio modificato ph dipendente. |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| CN100421648C (zh) * | 2006-08-15 | 2008-10-01 | 苏州市立医院 | 氢化考的松灌肠剂及其制备方法 |
| US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
| US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
| CN119097619A (zh) * | 2024-09-05 | 2024-12-10 | 中国人民解放军海军军医大学 | 乙酰基肉碱在制备预防和/或治疗炎症性肠病的药物中的应用 |
| CN119033751B (zh) * | 2024-09-05 | 2025-10-31 | 中国人民解放军海军军医大学 | 棕榈酰基肉碱在制备预防和/或治疗炎症性肠病的药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
| IT1181682B (it) * | 1985-06-11 | 1987-09-30 | Sigma Tau Ind Farmaceuti | Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto |
| IT1258370B (it) * | 1992-03-02 | 1996-02-26 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono. |
| IT1254314B (it) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. |
| IT1277898B1 (it) * | 1995-08-03 | 1997-11-12 | Mendes Srl | Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie |
| IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
-
1996
- 1996-06-06 IT IT96RM000396A patent/IT1284661B1/it active IP Right Grant
-
1997
- 1997-05-31 TW TW086107648A patent/TW585763B/zh not_active IP Right Cessation
- 1997-06-03 EP EP97830270A patent/EP0811376B1/de not_active Expired - Lifetime
- 1997-06-03 PT PT97830270T patent/PT811376E/pt unknown
- 1997-06-03 ES ES97830270T patent/ES2185897T3/es not_active Expired - Lifetime
- 1997-06-03 DE DE69716341T patent/DE69716341T2/de not_active Expired - Lifetime
- 1997-06-03 AT AT97830270T patent/ATE226069T1/de active
- 1997-06-03 DK DK97830270T patent/DK0811376T3/da active
- 1997-06-04 CA CA002206995A patent/CA2206995C/en not_active Expired - Fee Related
- 1997-06-04 US US08/868,627 patent/US6013670A/en not_active Expired - Lifetime
- 1997-06-05 KR KR1019970023288A patent/KR100450293B1/ko not_active Expired - Fee Related
- 1997-06-05 MX MX9704150A patent/MX9704150A/es unknown
- 1997-06-05 ZA ZA9704946A patent/ZA974946B/xx unknown
- 1997-06-06 JP JP14907397A patent/JP4171085B2/ja not_active Expired - Fee Related
-
1999
- 1999-11-16 US US09/441,328 patent/US6143785A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69716341D1 (de) | 2002-11-21 |
| ZA974946B (en) | 1997-12-18 |
| CA2206995C (en) | 2007-10-30 |
| ITRM960396A0 (it) | 1996-06-06 |
| DK0811376T3 (da) | 2003-03-10 |
| ES2185897T3 (es) | 2003-05-01 |
| TW585763B (en) | 2004-05-01 |
| JPH1059845A (ja) | 1998-03-03 |
| KR980000444A (ko) | 1998-03-30 |
| KR100450293B1 (ko) | 2004-11-20 |
| DE69716341T2 (de) | 2003-06-05 |
| JP4171085B2 (ja) | 2008-10-22 |
| EP0811376A1 (de) | 1997-12-10 |
| IT1284661B1 (it) | 1998-05-21 |
| PT811376E (pt) | 2003-03-31 |
| US6143785A (en) | 2000-11-07 |
| ITRM960396A1 (it) | 1997-12-06 |
| CA2206995A1 (en) | 1997-12-06 |
| US6013670A (en) | 2000-01-11 |
| EP0811376B1 (de) | 2002-10-16 |
| MX9704150A (es) | 1997-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59310327D1 (de) | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| DE3784693D1 (de) | Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. | |
| ATE332702T1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| ATE226069T1 (de) | Verwendung von alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur behandlung von entzündlichen darmerkrankungen | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| DE69426320D1 (de) | Verwendung von silikon/fluorsilikon kopolymeröl zur herstellung eines arzneimittels zur behandlung von augenerkrankungen | |
| DE69429806D1 (de) | Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung | |
| ATE274349T1 (de) | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs | |
| DE69232911D1 (de) | Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| PL338071A1 (en) | Treatment of intestinal and vesical inflammatory disorders | |
| DE68924714D1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
| ATE162076T1 (de) | Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer | |
| ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
| DE69233725D1 (de) | Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren | |
| ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
| DE69003960D1 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
| DE69720064D1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
| DE3578374D1 (de) | Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen. | |
| ATE112276T1 (de) | Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0811376 Country of ref document: EP |